Patient Involvement and Digitalization in Rare Diseases and Cancer: Interview with Christof von Kalle
Christof von Kalle
Chair for Clinical Translational Sciences
BIH @ Charite
Format: 20 Minute Interview
Register free to attend thought leadership
Do you have a question you’d like Christof von Kalle to answer during the session?
Register and askRelated posts
Animal Free 3D Cell Culture and Organoid Growth: Interview with Aline Miller, University of Manchester
Developing CAR T for Solid Tumours: Interview with John Bridgeman, ImmunoKey
Designing Next-Gen Biomaterials: Peptide Hydrogels in 3D Culture & Regenerative Platforms
Commissioning ATMPs for the NHS: Interview with Sarah McAleer & Kiran Moyo, NHS England
Centralised Off-The-Shelf Cell Therapies: Interview with Volker Huppert, Glycostem
Upcoming events
NextGen Biomed 2026
In-Person
NextGen Biomed has evolved over 18 years, from six individual events and communities into a unified platform designed to address the need for interdisciplinary collaboration, year-round engagement, and streamlined innovation and best practice sharing.
Computational Antibody Discovery
Online
Explore cutting-edge advancements in computational antibody discovery platforms, featuring real-world case studies on AI/ML in antibody engineering.
Register for free to view
-
Quickly grasp the key takeaways from cutting-edge biomed research with our bite-sized 5-minute video summaries, before diving into the full presentations from leaders in the industry.
-
From cutting-edge discoveries to real-world applications, see how new research can impact your work, from the lab to commercialisation.
-
Join a community of next-gen scientists, academics and researchers, stay connected, and engage with the latest innovations shaping the future of biomedicine.
Already registered? Sign In.